• Home
  • Company
    • Investors
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Literature
  • News
  • Contact
    • Careers

Kylin Therapeutics receives research funding for its nanoparticle cancer therapy

WEST LAFAYETTE, Ind. – Officials of Kylin Therapeutics Inc. announced Tuesday, Nov. 9, that they received a therapeutic discovery project grant from the U.S. Internal Revenue Service that will advance the company’s pRNA nanoparticle cancer treatment research. The nearly $250,000 award from the IRS is in the form of a grant designed for biotechnology research [...]

RNA Therapeutics Expert Joins Kylin’s Scientific Advisory Board

Officials at Kylin Therapeutics, Inc. announced Wednesday (June 30) that RNA interference and genetics expert John J. Rossi, Ph.D., will serve on the company’s Scientific Advisory Board. “John Rossi brings more than 30 years of research and experience in RNA interference (RNAi), molecular biology, genetics and gene therapy to our team,” said Eric Davis, president [...]

Engineering RNA for Targeted siRNA Delivery and Medical Application.

Department of Biomedical Engineering College of Engineering/College of Medicine, University of Cincinnati, Cincinnati, OH 45221, USA. RNA engineering for nanotechnology and medical applications is an exciting emerging research field. RNA has intrinsically defined features on the nanometre scale and is a particularly interesting candidate for such applications due to its amazing diversity, flexibility and versatility [...]

Latest News: Kylin Therapeutics receives research funding for its nanoparticle cancer therapy Latest News: RNA Therapeutics Expert Joins Kylin’s Scientific Advisory Board

Recent News

  • Kylin Therapeutics receives research funding for its nanoparticle cancer therapy
  • RNA Therapeutics Expert Joins Kylin’s Scientific Advisory Board

CEO Updates

  • #Kylin Therapeutics receives funding for its #RNA #nanotech #cancer treatment: http://www.kylintherapeutics.com/news/ 2010-11-10
  • #Kylin featured in Genetic Engineering and Biotechnology News: http://tinyurl.com/327lwtj 2010-10-09
  • Third Rock's, Mark Levin says, "discovery is where most important [Pharma] collaborations get started" today. http://tinyurl.com/2cfvuv5 2010-09-24
  • More updates...

Navigation

  • Company
    • Investors
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Literature
  • News
  • Contact
    • Careers
Copyright © Kylin Therapeutics | Designed by Denvelopers, LLC top